撒哈拉以南非洲HIV感染者抑制性ART前后血浆炎症与免疫激活生物标志物研究
该研究评估了5个非洲国家398例HIV感染成人的免疫生物标志物谱,并与90例HIV未感染者对照。所有标志物在ART启动后下降,但CXCL10、LBP、CRP、sCD163和sCD14在ART期间仍显著高于对照,提示持续性单核/巨噬细胞激活、炎症和微生物易位。
要点
- ART启动后所有生物标志物下降,但部分仍高于HIV未感染者。
- ART前高HIV病毒载量与CXCL10升高相关,结核共感染与sCD14升高相关。
- ART前各标志物高水平可强烈预测ART期间残余免疫激活。
核心结论
- 尽管ART启动后生物标志物总体下降,HIV感染者仍存在持续性单核/巨噬细胞激活、炎症和微生物易位。
研究设计与样本
- 研究纳入5个非洲国家的398例HIV感染成人,并与90例HIV未感染者参照组比较。
主要发现
- ART启动后所有生物标志物均下降。
- ART期间CXCL10、LBP、CRP、sCD163和sCD14水平显著高于HIV未感染者参照组。
- ART前高HIV病毒载量与CXCL10升高相关,结核共感染与sCD14升高相关。
- ART前各生物标志物高水平强烈预测ART期间残余免疫激活。
- CCL2、LBP、CRP和IL-6在不同国家间存在差异表达。
临床怎么用
- 监测ART前生物标志物水平有助于识别ART期间残余免疫激活高风险患者。
局限性
- 残余免疫失调的临床意义尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We evaluated immune biomarker profiles in human immunodeficiency virus (HIV)-infected adults (n = 398) from 5 African countries. Although all biomarkers decreased after antiretroviral therapy (ART) initiation, levels of C-X-C chemokine ligand 10 (CXCL10), lipopolysaccharide-binding protein, C-reactive protein, soluble CD163, and soluble scavenger receptor CD14 were significantly higher during ART than in an HIV-uninfected reference group (n = 90), indicating persistent monocyte/macrophage activation, inflammation, and microbial translocation. Before ART initiation, high HIV viral load was associated with elevated CXCL10 and tuberculosis coinfection was associated with elevated soluble CD14. High pre-ART levels of each biomarker strongly predicted residual immune activation during ART. Chemokine (C-C motif) ligand 2, lipopolysaccharide-binding protein, C-reactive protein, and interleukin 6 were differentially expressed between countries. Further research is needed on the clinical implications of residual immune dysregulation.
引用
- Kroeze S, Wit FW, Rossouw TM, et al. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy. J Infect Dis. 2019. PMID: 31086991. doi:10.1093/infdis/jiz252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。